PMID: 7025189Oct 4, 1980Paper

Acute myeloblastic leukemia in adults: a cure in sight?

Schweizerische medizinische Wochenschrift
C Sauter

Abstract

The author inquires what the chances are in 1980 of curing acute myeloblastic leukemia (AML) in adults. Efforts toward curative treatment are chiefly concentrated in three places: the basic science laboratories, the clinical laboratories, and the bedside. It remains an open question from which quarter the decisive findings for the prevention or cure of AML will come. For the time being, only clinical trials offer substantial help to AML sufferers. A small number of patients achieve many years of remission and are perhaps even cured, but it is impossible to predict what patients can expect longterm remissions. Painstaking investigation of this group of patients may provide the clue to curative treatment for AML as early as the present decade.

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.